Centerview Partners' strategic advisory practice delivers thoughtful, tailored solutions to our clients, consistent with our reputation for trusted, independent strategic and financial advice

Skip Navigation Links Centerview Partners's strategic advisory business serves some of the largest companies globally in a broad range of industries, with expertise across sectors comprising 70% of global GDP. From offices in New York, London, San Francisco and Los Angeles, our professionals are dedicated to providing discreet and independent strategic and financial advice, unencumbered by institutional constraints or conflicts of interest.

Our partners have deep experience across the most complex public and private company transactions. More than that, the firm's relationship-based approach with our clients means that our focus and expertise extends far beyond traditional investment banking advisory services. We look to add value to our clients not only in transaction situations but also during the majority of the time when their focus is on managing their existing businesses.

The firm has advised on many significant transactions in recent years, including:

  • Honeywell's intended spin off of its Resins and Chemicals business into a standalone, publicly traded company named AdvanSix, Inc.
  • Xerox's planned separation of its Document Technology and Business Process Outsourcing businesses into two independent public companies
  • Johnson Controls pending $16.5 billion merger with Tyco
  • Mylan's pending $10 billion acquisition of Meda
  • DreamWorks pending $3.8 billion sale to Comcast
  • Magnum Hunter''s $1.4 billion pre-arranged restructuring (ad hoc committee of noteholders)
  • Solera's $6.5 billion sale to Vista Equity Partners
  • Newell Rubbermaid's $20 billion acquisition of Jarden
  • Omnicare's $12.7 billion sale to CVS Health
  • Time Warner Cable's planned $79 billion merger with Charter Communications
  • GE's planned disposition of approximately $200 billion of GE Capital assets
  • Kraft's $58 billion merger with Heinz
  • Pharmacyclics $21 billion sale to AbbVie
  • P&G's $15 billion merger of its beauty business with Coty
  • Salix's $15.8 billion sale to Valeant Pharmaceuticals
  • Lorillard's $27.4 billion sale to Reynolds American and related $7.1 billion divestiture to Imperial Tobacco
  • MICROS' $5.3 billion sale to Oracle
  • GE's $13.5 billion acquisition of Alstom's Thermal, Renewables and Grid business
  • Onyx Pharmaceuticals $10 billion sale to Amgen
  • Fidelity National Information Services' $9.1 billion acquisition of SunGard
  • Heinz's $28 billion sale to Berkshire Hathaway and 3G
  • Silver Lake Partners' $25 billion acquisition of Dell
  • News Corp's $9.0 billion separation of its publishing and media & entertainment businesses
  • JCPenney's $2.25 billion capital raise
  • Alliance Boots $27 billion unique two-step transaction with Walgreens
  • Activision Blizzard's $8.2 billion repurchase of shares from Vivendi
  • ResCap’s chapter 11 restructuring with aggregate indebtedness of $15.3 billion
  • Pfizer’s $11.9 billion sale of its Pediatric Nutrition business to Nestlé
  • Cisco’s $5.0 billion acquisition of NDS Group
  • Motorola Mobility's $12.5 billion sale to Google
  • Capital One's $9.0 billion acquisition of ING Direct

© 2008 - 2018 Centerview Partners Holdings LP. All Rights Reserved. Centerview Partners LLC, member SIPC